Watch for revenue recognition from the $49.5M in purchase orders in 2026 and any updates on strategic alternatives. The stock may react positively if procurement conversions accelerate, but remains high-risk due to minimal current revenue and history of losses.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Mar 27 $0.3930entry
- T+1 · 8mo ago +1.02%α +1.38% · $0.3970
- T+5 · 8mo ago +4.58%α +0.72% · $0.4110
- T+20 · 7mo ago +29.52%α +16.78% · $0.5090
- T+60 · 5mo ago +332.57%α +316.64% · $1.70
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Inspira Technologies reported minimal revenue of $289,000 in 2025 with a net loss of $13.22 million, reflecting ongoing commercialization challenges. Despite the weak financials, the company secured $49.5 million in binding purchase orders expected to drive revenue in 2026 and raised $4.75 million in a follow-on offering, improving liquidity and Nasdaq compliance. Clinical deployments are expanding, and the company is advancing its HYLA blood sensor platform.
Key Financial Metrics
Key Facts
- Reported $289,000 in revenue for 2025, up from $0 in 2024
- Net loss widened to $13.22 million in 2025 from $11.05 million in 2024
- Secured $49.5 million in binding purchase orders, with revenue expected in 2026
- Raised $4.75 million in a registered direct offering post-year-end
- Cash and equivalents dropped to $3.16 million from $5.78 million in 2024
- Appointed new VP of Global Sales and expanded clinical use at U.S. medical centers
- Terminated non-binding term sheet with Bio-View Ltd., evaluating other strategic options
Financial Impact
Revenue of $289,000 is negligible; $49.5M in future orders represents significant potential upside in 2026
Risk Factors
- Minimal current revenue and sustained losses raise sustainability concerns
- Revenue from $49.5M in orders is deferred and subject to procurement delays
- High share-based compensation and executive turnover may signal governance risks
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3263441 |
Track record
13 reports on IINN
3 of 3 bullish or bearish reports moved the stock their way by T+5. Best: +308.27% at T+5 after the May 18, 2026 report. 3 of 3 went positive at some point.
Filters
- Oct 9, 20265w ago 6-K Neutral 4/10 No price data
- May 29, 202624w ago Press Release Mixed 5/10 Entry $3.07 to $1.87 ▼ −39.09% −38.80% vs SPY
- May 18, 202626w ago Press Release Bullish 5/10 Entry $0.3723 to $1.52 ▲ +308.27% +306.65% vs SPY
- May 11, 202627w ago Press Release Neutral 5/10 Entry $0.4070 to $0.3720 ▼ −8.60% −8.51% vs SPY
- May 1, 202628w ago Press Release Neutral 4/10 Entry $0.4680 to $0.4500 ▼ −3.85% −6.19% vs SPY
- Apr 16, 202630w ago Press Release Bullish 6/10 Entry $0.4950 to $0.5400 ▲ +9.09% +8.11% vs SPY
- Apr 14, 202630w ago Press Release Neutral 3/10 Entry $0.4750 to $0.5800 ▲ +22.11% +20.71% vs SPY
- Apr 13, 202631w ago Press Release Mixed 5/10 Entry $0.5080 to $0.5870 ▲ +15.55% +12.26% vs SPY
- Apr 6, 202632w ago Press Release Neutral 4/10 Entry $0.4110 to $0.5080 ▲ +23.60% +19.47% vs SPY
- Apr 6, 202632w ago Press Release Bullish 7/10 Entry $0.4110 to $0.5080 ▲ +23.60% +19.47% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers